Afficher la notice abrégée

dc.contributor.authorDANNAOUI, Eric
dc.contributor.authorGABRIEL, Frédéric
dc.contributor.authorGABOYARD, Manuel
dc.contributor.authorAUDEBERT, Lucile
dc.contributor.authorLAGARDERE, Gaëlle
dc.contributor.authorQUESNE, Gilles
dc.contributor.authorGODICHAUD, Sandrine
dc.contributor.authorVERWEIJ, Paul
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorACCOCEBERRY, Isabelle
IDREF: 075520818
dc.contributor.authorBOUGNOUX, Marie-Elisabeth
dc.date.accessioned2023-06-28T09:58:51Z
dc.date.available2023-06-28T09:58:51Z
dc.date.issued2017-11
dc.identifier.issn0095-1137
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/183216
dc.description.abstractEnABSTRACT Aspergillus fumigatus is the main species responsible for aspergillosis in humans. The diagnosis of aspergillosis remains difficult, and the rapid emergence of azole resistance in A. fumigatus is worrisome. The aim of this study was to validate the new MycoGENIE A. fumigatus real-time PCR kit and to evaluate its performance on clinical samples for the detection of A. fumigatus and its azole resistance. This multiplex assay detects DNA from the A. fumigatus species complex by targeting the multicopy 28S rRNA gene and specific TR 34 and L98H mutations in the single-copy-number cyp51A gene of A. fumigatus . The specificity of cyp51A mutation detection was assessed by testing DNA samples from 25 wild-type or mutated clinical A. fumigatus isolates. Clinical validation was performed on 88 respiratory samples obtained from 62 patients and on 69 serum samples obtained from 16 patients with proven or probable aspergillosis and 13 patients without aspergillosis. The limit of detection was <1 copy for the Aspergillus 28S rRNA gene and 6 copies for the cyp51A gene harboring the TR 34 and L98H alterations. No cross-reactivity was detected with various fungi and bacteria. All isolates harboring the TR 34 and L98H mutations were accurately detected by quantitative PCR (qPCR) analysis. With respiratory samples, qPCR results showed a sensitivity and specificity of 92.9% and 90.1%, respectively, while with serum samples, the sensitivity and specificity were 100% and 84.6%, respectively. Our study demonstrated that this new real-time PCR kit enables sensitive and rapid detection of A. fumigatus DNA and azole resistance due to TR 34 and L98H mutations in clinical samples.
dc.language.isoen
dc.publisherAmerican Society for Microbiology
dc.title.enMolecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit
dc.typeArticle de revueen_US
dc.identifier.doi10.1128/JCM.01032-17
dc.subject.halSciences du Vivant [q-bio]
bordeaux.journalJournal of Clinical Microbiologyen_US
bordeaux.page3210-3218
bordeaux.volume55
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.issue11
bordeaux.institutionCNRS
bordeaux.peerReviewedoui
bordeaux.import.sourcehal
hal.identifierhal-03997762
hal.version1
hal.exportfalse
workflow.import.sourcehal
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Journal%20of%20Clinical%20Microbiology&amp;rft.date=2017-11&amp;rft.volume=55&amp;rft.issue=11&amp;rft.spage=3210-3218&amp;rft.epage=3210-3218&amp;rft.eissn=0095-1137&amp;rft.issn=0095-1137&amp;rft.au=DANNAOUI,%20Eric&amp;GABRIEL,%20Fr%C3%A9d%C3%A9ric&amp;GABOYARD,%20Manuel&amp;AUDEBERT,%20Lucile&amp;LAGARDERE,%20Ga%C3%ABlle&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée